Exosomal circGSE1, derived from HCC cells, could induce the expansion of Tregs by regulating the miR-324-5p/TGFBR1/Smad3 axis, and thus serves as a promising biomarker for HCC immunotherapy [107]. The gene discussed is TGFBR1; the disease is hepatocellular carcinoma.